IFITM1 inhibits trophoblast invasion and is induced in placentas associated with IFN-mediated pregnancy diseases.

Biological sciences Cell biology Virology

Journal

iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038

Informations de publication

Date de publication:
21 Jul 2023
Historique:
received: 07 02 2023
revised: 05 05 2023
accepted: 12 06 2023
medline: 12 7 2023
pubmed: 12 7 2023
entrez: 12 7 2023
Statut: epublish

Résumé

Interferon-induced transmembrane proteins (IFITMs) are restriction factors that block many viruses from entering cells. High levels of type I interferon (IFN) are associated with adverse pregnancy outcomes, and IFITMs have been shown to impair the formation of syncytiotrophoblast. Here, we examine whether IFITMs affect another critical step of placental development, extravillous cytotrophoblast (EVCT) invasion. We conducted experiments using

Identifiants

pubmed: 37434700
doi: 10.1016/j.isci.2023.107147
pii: S2589-0042(23)01224-5
pmc: PMC10331461
doi:

Types de publication

Journal Article

Langues

eng

Pagination

107147

Informations de copyright

© 2023 The Author(s).

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Références

Cell. 2000 Apr 14;101(2):173-85
pubmed: 10786833
Immunity. 2018 Sep 18;49(3):397-412
pubmed: 30231982
Environ Health Perspect. 2019 Feb;127(2):27003
pubmed: 30810372
Mol Hum Reprod. 2015 May;21(5):435-51
pubmed: 25667199
Retrovirology. 2017 Nov 21;14(1):53
pubmed: 29162141
Biomed Res Int. 2019 May 8;2019:9085435
pubmed: 31205947
Physiology (Bethesda). 2005 Jun;20:180-93
pubmed: 15888575
Cancer Lett. 2017 May 1;393:76-85
pubmed: 28223169
Virol J. 2012 Nov 01;9:255
pubmed: 23116176
J Bone Miner Res. 2008 Sep;23(9):1497-508
pubmed: 18442316
Am J Reprod Immunol. 2013 Nov;70(5):412-27
pubmed: 23790133
PLoS One. 2014 Aug 08;9(8):e104341
pubmed: 25105503
Am J Pathol. 2000 Dec;157(6):1759-68
pubmed: 11106547
Cell Stem Cell. 2018 Jan 4;22(1):50-63.e6
pubmed: 29249463
Placenta. 2021 Aug;111:76-81
pubmed: 34175522
Biomark Res. 2016 May 14;4:10
pubmed: 27186374
Arthritis Rheumatol. 2015 Apr;67(4):977-87
pubmed: 25603823
Lancet. 2001 Jan 6;357(9249):53-6
pubmed: 11197372
Proc Natl Acad Sci U S A. 2017 Feb 21;114(8):1940-1945
pubmed: 28167787
Cell Host Microbe. 2014 Dec 10;16(6):736-47
pubmed: 25464829
Int J Mol Sci. 2022 Jul 29;23(15):
pubmed: 35955565
Am J Obstet Gynecol. 2017 Aug;217(2):200.e1-200.e17
pubmed: 28347715
Front Immunol. 2022 Nov 18;13:1042368
pubmed: 36466909
Anat Rec (Hoboken). 2013 Mar;296(3):378-81
pubmed: 23382140
Reprod Fertil Dev. 2019 May;31(6):1057-1067
pubmed: 30944060
Cells. 2019 Sep 26;8(10):
pubmed: 31561453
Nat Rev Microbiol. 2016 Nov;14(11):707-715
pubmed: 27573577
Mol Diagn Ther. 2020 Aug;24(4):433-441
pubmed: 32394410
Cell Rep. 2013 Nov 27;5(4):895-908
pubmed: 24268777
Science. 2019 Jul 12;365(6449):176-180
pubmed: 31296770
J Cell Sci. 1991 Aug;99 ( Pt 4):681-92
pubmed: 1769999
Cancer Gene Ther. 2020 Feb;27(1-2):38-44
pubmed: 30923336
Clin Cancer Res. 2008 Oct 1;14(19):6097-105
pubmed: 18829488
PLoS Pathog. 2013 Jan;9(1):e1003124
pubmed: 23358889
Placenta. 2012 Dec;33(12):971-6
pubmed: 23102999
Hypertension. 2008 Apr;51(4):970-5
pubmed: 18259009
Cancer Lett. 2015 Nov 1;368(1):135-143
pubmed: 26259513
J Obstet Gynaecol India. 2018 Feb;68(1):27-32
pubmed: 29391672
Oncol Rep. 2013 Jul;30(1):171-8
pubmed: 23624618
Am J Pathol. 2020 May;190(5):970-976
pubmed: 32084366
Placenta. 1980 Jan-Mar;1(1):3-19
pubmed: 7443635
PLoS One. 2013 Nov 11;8(11):e79636
pubmed: 24244532
Nat Cell Biol. 2016 Dec;18(12):1311-1323
pubmed: 27842057
Int J Mol Sci. 2023 Mar 12;24(6):
pubmed: 36982514
J Biol Chem. 2019 Dec 27;294(52):19844-19851
pubmed: 31735710

Auteurs

Séverine A Degrelle (SA)

Université Paris Cité, INSERM, UMR-S1139, Pathophysiology & Pharmacotoxicology of the Human Placenta, Pre- & Post-natal Microbiota (3PHM), 75006 Paris, France.
Inovarion, 75005 Paris, France.

Julian Buchrieser (J)

Virus and Immunity Unit, Institut Pasteur, 75015 Paris, France.
CNRS-UMR3569, 75015 Paris, France.

Anne Dupressoir (A)

Unité Physiologie et Pathologie Moléculaires des Rétrovirus Endogènes et Infectieux, Hôpital Gustave Roussy, 94805 Villejuif, France.
UMR 9196, Université Paris-Sud, 91405 Orsay, France.

Françoise Porrot (F)

Unité Physiologie et Pathologie Moléculaires des Rétrovirus Endogènes et Infectieux, Hôpital Gustave Roussy, 94805 Villejuif, France.
UMR 9196, Université Paris-Sud, 91405 Orsay, France.

Laurence Loeuillet (L)

Service d'Histologie-Embryologie-Cytogénétique, Hôpital Necker-Enfants Malades, AP-HP, 75015 Paris, France.

Olivier Schwartz (O)

Virus and Immunity Unit, Institut Pasteur, 75015 Paris, France.
CNRS-UMR3569, 75015 Paris, France.
Vaccine Research Institute, 94010 Créteil, France.

Thierry Fournier (T)

Université Paris Cité, INSERM, UMR-S1139, Pathophysiology & Pharmacotoxicology of the Human Placenta, Pre- & Post-natal Microbiota (3PHM), 75006 Paris, France.

Classifications MeSH